NanoString Technologies ROE 2011-2019 | NSTG

Current and historical return on equity (ROE) values for NanoString Technologies (NSTG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. NanoString Technologies ROE for the three months ending June 30, 2019 was -118.03%.
NanoString Technologies ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $-0.08B $0.09B -117.04%
2019-03-31 $-0.08B $0.10B -165.80%
2018-12-31 $-0.08B $0.04B -250.41%
2018-09-30 $-0.07B $0.05B -206.35%
2018-06-30 $-0.06B $0.01B -201.68%
2018-03-31 $-0.04B $0.03B -108.64%
2017-12-31 $-0.04B $0.04B -131.34%
2017-09-30 $-0.05B $0.05B -177.36%
2017-06-30 $-0.05B $0.05B -340.74%
2017-03-31 $-0.05B $-0.00B -10400.00%
2016-12-31 $-0.05B $0.01B -1371.43%
2016-09-30 $-0.05B $-0.01B -818.18%
2016-06-30 $-0.04B $0.00B -314.29%
2016-03-31 $-0.05B $0.01B -200.00%
2015-12-31 $-0.05B $0.02B -159.29%
2015-09-30 $-0.05B $0.03B -139.13%
2015-06-30 $-0.05B $0.03B -122.16%
2015-03-31 $-0.05B $0.03B -106.53%
2014-12-31 $-0.05B $0.05B -79.67%
2014-09-30 $-0.05B $0.06B -79.31%
2014-06-30 $-0.04B $0.07B -77.78%
2014-03-31 $-0.04B $0.08B -97.30%
2013-12-31 $-0.04B $0.03B -194.44%
2013-09-30 $-0.03B $0.04B -250.98%
2013-06-30 $-0.03B $-0.00B -1127.27%
2013-03-31 $-0.03B $0.00B -861.54%
2012-12-31 $-0.02B $0.01B -920.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.942B $0.107B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.355B 27.89
Medtronic (MDT) Ireland $136.463B 19.49
Stryker (SYK) United States $80.545B 27.85
Boston Scientific (BSX) United States $58.324B 28.29
Baxter (BAX) United States $43.795B 26.56
EssilorLuxottica Societe Anonyme (ESLOY) France $30.720B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.744B 17.76
Coloplast (CLPBY) Denmark $26.309B 42.00
Lonza Group Ag (LZAGY) Switzerland $25.750B 0.00
Terumo (TRUMY) Japan $23.727B 27.28
Smith & Nephew SNATS (SNN) United Kingdom $19.987B 0.00
ResMed (RMD) United States $19.012B 36.26
Sunny Optical Technology (SNPTF) China $13.031B 0.00
Bio-Rad Laboratories (BIO) United States $9.510B 50.98
Canopy Growth (CGC) Canada $9.478B 0.00
Insulet (PODD) United States $9.126B 540.75
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.016B 20.92
Haemonetics (HAE) United States $6.910B 52.15
Perrigo (PRGO) Ireland $6.214B 11.45
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
Aurora Cannabis (ACB) Canada $5.769B 56.70
GW Pharmaceuticals (GWPH) United Kingdom $4.612B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.587B 59.66
ICU Medical (ICUI) United States $3.452B 22.39
NuVasive (NUVA) United States $3.286B 26.19
Hutchison China MediTech (HCM) China $2.661B 0.00
Quidel (QDEL) United States $2.508B 24.91
Agios Pharmaceuticals (AGIO) United States $2.497B 0.00
National Vision Holdings (EYE) United States $2.260B 48.78
Cardiovascular Systems (CSII) United States $1.637B 0.00
Aphria (APHA) $1.496B 0.00
Phibro Animal Health (PAHC) United States $1.215B 18.20
AtriCure (ATRC) United States $1.045B 0.00
VAREX IMAGING (VREX) United States $0.981B 22.60
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.862B 20.36
Lantheus Holdings (LNTH) United States $0.850B 22.34
Eagle Pharmaceuticals (EGRX) United States $0.772B 19.67
Cerus (CERS) United States $0.731B 0.00
MacroGenics (MGNX) United States $0.708B 0.00
Quanterix (QTRX) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.621B 0.00
LeMaitre Vascular (LMAT) United States $0.615B 36.47
Surmodics (SRDX) United States $0.597B 113.41
OraSure Technologies (OSUR) United States $0.441B 20.40
Meridian Bioscience (VIVO) United States $0.427B 13.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.413B 0.00
BioLife Solutions (BLFS) United States $0.361B 118.69
United Health Products (UEEC) United States $0.357B 0.00
Utah Medical Products (UTMD) United States $0.356B 26.05
Zynex (ZYXI) United States $0.319B 33.86
Owens & Minor (OMI) United States $0.304B 9.11
Vapotherm (VAPO) United States $0.251B 0.00
Bovie Medical (APYX) United States $0.248B 0.00
Chimerix (CMRX) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Fonar (FONR) United States $0.151B 7.97
Female Health (VERU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 20.55
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.054B 0.00
Trinity Biotech (TRIB) Ireland $0.045B 15.58
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00